Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 53

1.

Nanoformulated Zoledronic Acid Boosts the Vδ2 T Cell Immunotherapeutic Potential in Colorectal Cancer.

Di Mascolo D, Varesano S, Benelli R, Mollica H, Salis A, Zocchi MR, Decuzzi P, Poggi A.

Cancers (Basel). 2019 Dec 31;12(1). pii: E104. doi: 10.3390/cancers12010104.

2.

Multifocal Signal Modulation Therapy by Celecoxib: A Strategy for Managing Castration-Resistant Prostate Cancer.

Benelli R, Barboro P, Costa D, Astigiano S, Barbieri O, Capaia M, Poggi A, Ferrari N.

Int J Mol Sci. 2019 Dec 3;20(23). pii: E6091. doi: 10.3390/ijms20236091.

3.

Functional Interaction of Hypoxia-Inducible Factor 2-Alpha and Autophagy Mediates Drug Resistance in Colon Cancer Cells.

Saint-Martin A, Martínez-Ríos J, Castañeda-Patlán MC, Sarabia-Sánchez MA, Tejeda-Muñoz N, Chinney-Herrera A, Soldevila G, Benelli R, Santoyo-Ramos P, Poggi A, Robles-Flores M.

Cancers (Basel). 2019 May 30;11(6). pii: E755. doi: 10.3390/cancers11060755.

4.

Human Gut-Associated Natural Killer Cells in Health and Disease.

Poggi A, Benelli R, Venè R, Costa D, Ferrari N, Tosetti F, Zocchi MR.

Front Immunol. 2019 May 3;10:961. doi: 10.3389/fimmu.2019.00961. eCollection 2019. Review.

5.

Beta-tricalcium phosphate ceramic triggers fast and robust bone formation by human mesenchymal stem cells.

Pereira RC, Benelli R, Canciani B, Scaranari M, Daculsi G, Cancedda R, Gentili C.

J Tissue Eng Regen Med. 2019 Jun;13(6):1007-1018. doi: 10.1002/term.2848. Epub 2019 Apr 15.

PMID:
30811859
6.

Targeting the Epidermal Growth Factor Receptor Can Counteract the Inhibition of Natural Killer Cell Function Exerted by Colorectal Tumor-Associated Fibroblasts.

Costa D, Venè R, Benelli R, Romairone E, Scabini S, Catellani S, Rebesco B, Mastracci L, Grillo F, Minghelli S, Loiacono F, Zocchi MR, Poggi A.

Front Immunol. 2018 May 29;9:1150. doi: 10.3389/fimmu.2018.01150. eCollection 2018.

7.

Prostaglandin-endoperoxide synthase 2 (cyclooxygenase-2), a complex target for colorectal cancer prevention and therapy.

Benelli R, Venè R, Ferrari N.

Transl Res. 2018 Jun;196:42-61. doi: 10.1016/j.trsl.2018.01.003. Epub 2018 Feb 2. Review.

PMID:
29421522
8.

The ErbB family and androgen receptor signaling are targets of Celecoxib in prostate cancer.

Brizzolara A, Benelli R, Venè R, Barboro P, Poggi A, Tosetti F, Ferrari N.

Cancer Lett. 2017 Aug 1;400:9-17. doi: 10.1016/j.canlet.2017.04.025. Epub 2017 Apr 25.

PMID:
28450158
9.

Zoledronate can induce colorectal cancer microenvironment expressing BTN3A1 to stimulate effector γδ T cells with antitumor activity.

Zocchi MR, Costa D, Venè R, Tosetti F, Ferrari N, Minghelli S, Benelli R, Scabini S, Romairone E, Catellani S, Profumo A, Poggi A.

Oncoimmunology. 2017 Jan 6;6(3):e1278099. doi: 10.1080/2162402X.2016.1278099. eCollection 2017.

10.

A humanized system to expand in vitro amniotic fluid-derived stem cells intended for clinical application.

Martinelli D, Pereira RC, Mogni M, Benelli R, Mastrogiacomo M, Coviello D, Cancedda R, Gentili C.

Cytotherapy. 2016 Mar;18(3):438-51. doi: 10.1016/j.jcyt.2015.11.020.

PMID:
26857233
11.

NCR(+)ILC3 concentrate in human lung cancer and associate with intratumoral lymphoid structures.

Carrega P, Loiacono F, Di Carlo E, Scaramuccia A, Mora M, Conte R, Benelli R, Spaggiari GM, Cantoni C, Campana S, Bonaccorsi I, Morandi B, Truini M, Mingari MC, Moretta L, Ferlazzo G.

Nat Commun. 2015 Sep 23;6:8280. doi: 10.1038/ncomms9280.

PMID:
26395069
12.

Celecoxib increases EGF signaling in colon tumor associated fibroblasts, modulating EGFR expression and degradation.

Venè R, Tosetti F, Minghelli S, Poggi A, Ferrari N, Benelli R.

Oncotarget. 2015 May 20;6(14):12310-25.

13.

Glycogen synthase kinase 3 regulates cell death and survival signaling in tumor cells under redox stress.

Venè R, Cardinali B, Arena G, Ferrari N, Benelli R, Minghelli S, Poggi A, Noonan DM, Albini A, Tosetti F.

Neoplasia. 2014 Sep;16(9):710-22. doi: 10.1016/j.neo.2014.07.012.

14.

Chronic lymphocytic leukemia nurse-like cells express hepatocyte growth factor receptor (c-MET) and indoleamine 2,3-dioxygenase and display features of immunosuppressive type 2 skewed macrophages.

Giannoni P, Pietra G, Travaini G, Quarto R, Shyti G, Benelli R, Ottaggio L, Mingari MC, Zupo S, Cutrona G, Pierri I, Balleari E, Pattarozzi A, Calvaruso M, Tripodo C, Ferrarini M, de Totero D.

Haematologica. 2014 Jun;99(6):1078-87. doi: 10.3324/haematol.2013.091405. Epub 2014 Feb 21.

15.

Dual effect of platelet lysate on human articular cartilage: a maintenance of chondrogenic potential and a transient proinflammatory activity followed by an inflammation resolution.

Pereira RC, Scaranari M, Benelli R, Strada P, Reis RL, Cancedda R, Gentili C.

Tissue Eng Part A. 2013 Jun;19(11-12):1476-88. doi: 10.1089/ten.TEA.2012.0225.

PMID:
23360471
16.

Impact of CXCL1 overexpression on growth and invasion of prostate cancer cell.

Benelli R, Stigliani S, Minghelli S, Carlone S, Ferrari N.

Prostate. 2013 Jun;73(9):941-51. doi: 10.1002/pros.22640. Epub 2013 Jan 17.

PMID:
23334998
17.

A randomized, placebo-controlled, preoperative trial of allopurinol in subjects with colorectal adenoma.

Puntoni M, Branchi D, Argusti A, Zanardi S, Crosta C, Meroni E, Munizzi F, Michetti P, Coccia G, De Roberto G, Bandelloni R, Turbino L, Minetti E, Mori M, Salvi S, Boccardo S, Gatteschi B, Benelli R, Sonzogni A, DeCensi A.

Cancer Prev Res (Phila). 2013 Feb;6(2):74-81. doi: 10.1158/1940-6207.CAPR-12-0249. Epub 2012 Dec 4.

18.

Celecoxib induces proliferation and Amphiregulin production in colon subepithelial myofibroblasts, activating erk1-2 signaling in synergy with EGFR.

Benelli R, Venè R, Minghelli S, Carlone S, Gatteschi B, Ferrari N.

Cancer Lett. 2013 Jan 1;328(1):73-82. doi: 10.1016/j.canlet.2012.09.008. Epub 2012 Sep 23.

PMID:
23010081
19.

Xanthohumol impairs human prostate cancer cell growth and invasion and diminishes the incidence and progression of advanced tumors in TRAMP mice.

Venè R, Benelli R, Minghelli S, Astigiano S, Tosetti F, Ferrari N.

Mol Med. 2012 Dec 6;18:1292-302. doi: 10.2119/molmed.2012.00174.

20.

The AKT/NF-κB inhibitor xanthohumol is a potent anti-lymphocytic leukemia drug overcoming chemoresistance and cell infiltration.

Benelli R, Venè R, Ciarlo M, Carlone S, Barbieri O, Ferrari N.

Biochem Pharmacol. 2012 Jun 15;83(12):1634-42. doi: 10.1016/j.bcp.2012.03.006. Epub 2012 Mar 17.

PMID:
22445931

Supplemental Content

Loading ...
Support Center